#Sustainability #India #EcoVadis #Raichur #Shilpa Pharma

Shilpa Pharma Lifesciences Earns EcoVadis Gold Medal for Sustainability

Shilpa Pharma Lifesciences Limited, a significant subsidiary of Shilpa Medicare Limited, has been awarded the illustrious EcoVadis Gold Medal, affirming its exceptional sustainable business practices. This accolade is granted to firms that demonstrate exemplary commitments to Environmental, Social, and Governance (ESG) criteria, showcasing their ongoing dedication to responsible operations.

The company achieved an impressive score of 82 out of 100, positioning it in the 98th percentile globally, with over 130,000 businesses evaluated by EcoVadis. Such an outstanding performance underlines the high standards maintained by Shilpa Pharma in fostering responsible production and corporate governance practices. This recognition also emphasizes the company's commitment to sustainability and its ambition to remain resilient in an ever-evolving market landscape.

EcoVadis employs four key criteria for its assessments: environment, labor and human rights, ethics, and sustainable procurement. Shilpa Pharma Lifesciences's recognition as one of the highest-rated companies reflects its proactive efforts in promoting and implementing sustainable business practices.

Keshav Bhutada, CEO of Shilpa Pharma Lifesciences, commented on this significant achievement, stating, "Sustainability and innovation are integral components of our growth strategy. Our collaboration with innovative global companies on new chemical entities reflects our commitment to responsible manufacturing and ethical governance. The EcoVadis Gold Medal serves as a testament to our relentless pursuit of creating lasting value for patients and partners alike. We look forward to engaging with more innovative firms worldwide."

This achievement further solidifies Shilpa Pharma's reputation among clients, investors, and partners, reinforcing its status as a reliable global partner in manufacturing and contract development, with sustainability at the core of its operations.

About Shilpa Medicare Limited

Shilpa Medicare Limited stands as a leading Indian pharmaceutical company, focusing on developing, manufacturing, and marketing active pharmaceutical ingredients (APIs), formulations, and biological products in oncology, infectious diseases, and specialized sectors. Through its proficiency in complex generics, innovative drug delivery systems, and contract manufacturing services, Shilpa serves patients across more than 80 countries. For additional information, visit Shilpa Medicare.

Forward-Looking Statements

This release includes forward-looking statements regarding the company’s objectives, plans, and future performance expectations. Actual results may differ significantly due to risks and uncertainties related to regulatory approvals, clinical outcomes, market conditions, and competitive developments. Shilpa Medicare does not undertake any obligation to update the forward-looking statements to reflect subsequent events or circumstances.